Rep. Cammack's Ectopic Pregnancy Highlights Real Confusion in Emergency Rooms Over Abortion Laws

What Happened

Rep. Kat Cammack, R-Fla., described a medical emergency in 2024 in which she suffered a ruptured ectopic pregnancy at roughly five weeks gestation. The fetus had no heartbeat. Doctors told her she faced catastrophic internal bleeding, permanent organ damage, and potential death, and that the window to save her life if she ruptured could be "measured in minutes," according to Cammack's communications director Rafael Struve, speaking to the Daily Signal.

The standard treatment is methotrexate, a drug used to dissolve ectopic tissue before rupture. Cammack says hospital staff hesitated to administer it. The reason they gave her: messaging from pro-abortion advocacy groups, including an ad a nurse showed her, suggesting providers could face prosecution under Florida's abortion law.

What Florida Law Actually Says

Florida Statutes Section 390.0111 bans abortion after six weeks. It explicitly does NOT classify the removal of a dead fetus as an abortion.

The Centers for Disease Control and Prevention distinguishes between induced abortion and other pregnancy outcomes, and medical consensus generally excludes ectopic pregnancy treatment from the definition of abortion.

Struve was direct about the gap between law and what happened at the bedside: "No professional medical organization, and no state law, classifies treatment for a miscarriage or an ectopic pregnancy as an abortion."

Cammack's case is not an argument that abortion laws endangered her. It's an argument that false advertising about abortion laws endangered her.

The Misinformation Vector

Since the Supreme Court's 2022 ruling in Dobbs v. Jackson Women's Health Organization, multiple pro-abortion advocacy groups have run campaigns aimed at physicians and hospital staff in states with abortion restrictions. Some of that messaging has, according to Cammack's account, overstated what those laws actually prohibit.

The strongest concern from critics of post-Dobbs abortion laws deserves a fair hearing: state laws are often broadly written, enforcement is unpredictable, and physicians in Texas, Idaho, and other states have documented cases in which hospitals did delay care for pregnancy complications out of legal uncertainty. The American College of Obstetricians and Gynecologists has published guidance arguing that vague statutory language creates genuine clinical risk. That concern is real and has been raised by medical professionals who are not affiliated with any advocacy campaign.

But Cammack's case is in Florida, where the law carves out ectopic pregnancy explicitly. What her nurses cited was not the statute. It was an ad.

Legislation in Response

Cammack introduced the Truth in Women's Healthcare Act in response to her experience. Struve told the Daily Signal the bill is designed to "reaffirm the importance of accurate medical information and clear guidance for emergency departments, patients, lawmakers, and the public so that no woman is left in danger" because of confusion, whether that confusion comes from vague laws or from advocacy campaigns that misrepresent those laws.

The bill's specific text and current status in committee were not available in the sources reviewed for this article.

A Line That Has to Hold

The debate over abortion access is legitimate and ongoing. What is NOT a legitimate debate is whether ectopic pregnancy treatment is an abortion. It is not, under any state law currently in effect and under every major medical definition.

When advocacy groups on either side blur that line, patients pay for it. A nurse in a Florida emergency room showed a congresswoman an ad suggesting her doctors could be prosecuted for saving her life. That is a direct, documented consequence of misinformation in a clinical setting.

The genuine unresolved question is whether the Truth in Women's Healthcare Act, or any federal legislation, can reach the private advocacy groups responsible for the misleading ads, or whether the bill's scope is limited to clarifying guidance for providers and public agencies. That distinction will determine whether it addresses the actual mechanism Cammack described.